2-(Pyridin-4-yl)-1H-benzo[d]imidazole

Catalog No. :
ACTCJY689
CAS No. :
2208-59-5
Molecular Formula :
C12H9N3
Molecular Weight :
195.23

IUPAC Name:2-(pyridin-4-yl)-1H-benzo[d]imidazole

2-(Pyridin-4-yl)-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$134.00Login to see priceIn stockInquiry
100g98%$529.00Login to see priceIn stockInquiry
500g98%$2220.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyridin-4-yl)-1H-benzo[d]imidazole
IUPAC Name2-(pyridin-4-yl)-1H-benzo[d]imidazole
MDL No.MFCD00453948
Molecular FormulaC12H9N3
Molecular Weight195.23
SMILESC1(C2=CC=NC=C2)=NC3=CC=CC=C3N1
InChI KeyUYWWLYCGNNCLKE-UHFFFAOYSA-N
SynonymZ50129789 | BDBM55759 | SMR000282981 | 2-(4-Pyridinyl)-1H-benzimidazole | 2-(Pyridin-4(1H)-ylidene)-2H-benzo[d]imidazole | BB 0219594 | 2-(pyridin-4-yl)-1H-1,3-benzodiazole | SY051172 | F0191-4540 | MFCD00453948 | SR-01000391502 | 2-(pyridin-4-yl)-1h-benz
CAS No.2208-59-5
PubChem CID247634

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACTCJY689 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAPOJ750 route compound structure diagram
    ACAPOJ75016887-79-9 In Stock
  4. Then
  5. ACTCJY689 route product structure diagram
    ACTCJY6892208-59-5 In Stock
Inquiry

2. ACTCJY689 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBXKY017 route compound structure diagram
    ACBXKY017872-85-5 In Stock
  4. Then
  5. ACTCJY689 route product structure diagram
    ACTCJY6892208-59-5 In Stock
Inquiry

Comments (0)